NEW YORK & TRENTON, N.J.--(BUSINESS WIRE)--On Tuesday, March 25, New York Biotechnology Association (NYBA), the voice of New York State’s biotechnology industry, and BioNJ, the voice of the industry in New Jersey, will join together for newX2 BioCruise 2008, a biotechnology industry networking event and award ceremony on the Hudson River honoring Sol J. Barer, Ph.D., Chairman and CEO of Celgene Corporation, who will receive the Dr. Sol J. Barer Award for Vision, Innovation and Leadership from BioNJ, and Colin Goddard, Ph.D., CEO of OSI Pharmaceuticals, who will receive The Cures Start Here® Leadership Award from NYBA.
